Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Vermersch

Showing results (51-60 of 250) with videos related to

Pageof 25
Sort By:
International Journal of Emergency Medicine|May 4, 2010
Lumbar punctures: use and diagnostic efficiency in emergency medical departmentsBilal Majed, Hélène Zephir, Valérie Pichonnier-Cassagne, et al.
Current Medical Research and Opinion|December 17, 2020
Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: <i>post hoc</i> analysis of subgroups with and without prior disease-modifying drug treatmentPatrick Vermersch, Andrew Galazka, Fernando Dangond, et al.
Neurology|August 24, 2012
The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?Rémy Phan-Ba, Shibeshih Belachew, Olivier Outteryck, et al.
Proteomics|June 29, 2004
New antigenic candidates in multiple sclerosis: identification by serological proteome analysisLionel Almeras, Didier Lefranc, Hervé Drobecq, et al.
Neuromuscular Disorders : NMD|April 9, 2008
A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findingsMarc Bitoun, Tanya Stojkovic, Bernard Prudhon, et al.
Neurodegenerative Disease Management|August 3, 2022
The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summaryPatrick Vermersch, Andrew Galazka, Fernando Dangond, et al.
Neuroscience Letters|October 26, 2010
B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onsetCatalina Lee-Chang, Hélène Zéphir, Isabelle Top, et al.
Blood Advances|January 19, 2018
Successful treatment with fingolimod of graft-versus-host disease of the central nervous systemJordan Gauthier, Patrick Vermersch, Paul Chauvet, et al.
European Journal of Neurology|October 9, 2022
Diagnosis and treatment of progressive multiple sclerosis: A position paperCarlo Pozzilli, Maura Pugliatti, Patrick Vermersch, et al.
Muscle & Nerve|September 4, 2012
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter studyNicolas Collongues, Olivier Casez, Arnaud Lacour, et al.
Pageof 25

Showing results (51-60 of 250) with videos related to

Sort By:
Pageof 25
International Journal of Emergency Medicine|May 4, 2010
Lumbar punctures: use and diagnostic efficiency in emergency medical departmentsBilal Majed, Hélène Zephir, Valérie Pichonnier-Cassagne, et al.
Current Medical Research and Opinion|December 17, 2020
Efficacy of cladribine tablets in high disease activity patients with relapsing multiple sclerosis: <i>post hoc</i> analysis of subgroups with and without prior disease-modifying drug treatmentPatrick Vermersch, Andrew Galazka, Fernando Dangond, et al.
Neurology|August 24, 2012
The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?Rémy Phan-Ba, Shibeshih Belachew, Olivier Outteryck, et al.
Proteomics|June 29, 2004
New antigenic candidates in multiple sclerosis: identification by serological proteome analysisLionel Almeras, Didier Lefranc, Hervé Drobecq, et al.
Neuromuscular Disorders : NMD|April 9, 2008
A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findingsMarc Bitoun, Tanya Stojkovic, Bernard Prudhon, et al.
Neurodegenerative Disease Management|August 3, 2022
The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summaryPatrick Vermersch, Andrew Galazka, Fernando Dangond, et al.
Neuroscience Letters|October 26, 2010
B-cell subsets up-regulate α4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onsetCatalina Lee-Chang, Hélène Zéphir, Isabelle Top, et al.
Blood Advances|January 19, 2018
Successful treatment with fingolimod of graft-versus-host disease of the central nervous systemJordan Gauthier, Patrick Vermersch, Paul Chauvet, et al.
European Journal of Neurology|October 9, 2022
Diagnosis and treatment of progressive multiple sclerosis: A position paperCarlo Pozzilli, Maura Pugliatti, Patrick Vermersch, et al.
Muscle & Nerve|September 4, 2012
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter studyNicolas Collongues, Olivier Casez, Arnaud Lacour, et al.
Pageof 25